On the public citation graph

Promoters and Drags: Value Conversion Capability and the Dynamics of Value Capture in Biopharmaceutical Ventures Under Uncertainty

https://doi.org/10.2139/ssrn.6844801
0 signed · 28 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamapsychiatry.2014.1319openalex-snapshot
Placebo Response in Antipsychotic Clinical Trials
inferredcites →https://doi.org/10.1002/sej.4openalex-snapshot
Discovery and creation: alternative theories of entrepreneurial action
inferredcites →https://doi.org/10.1002/smj.640openalex-snapshot
Explicating dynamic capabilities: the nature and microfoundations of (sustainable) enterprise performance
inferredcites →https://doi.org/10.1016/j.jfineco.2019.06.011openalex-snapshot
How do venture capitalists make decisions?
inferredcites →https://doi.org/10.1016/j.jhealeco.2016.01.012openalex-snapshot
Innovation in the pharmaceutical industry: New estimates of R&D costs
inferredcites →https://doi.org/10.1016/j.ophtha.2004.12.035openalex-snapshot
Noncompliance with Ocular Hypotensive Treatment in Patients with Glaucoma or Ocular HypertensionAn Evidence-Based Review
inferredcites →https://doi.org/10.1016/s0169-7218(10)01014-2openalex-snapshot
The Financing of R&D and Innovation
inferredcites →https://doi.org/10.1016/s2213-2600(14)70101-8openalex-snapshot
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
inferredcites →https://doi.org/10.1016/s2213-2600(25)00239-5openalex-snapshot
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial
inferredcites →https://doi.org/10.1017/s1461145711001738openalex-snapshot
Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?
inferredcites →https://doi.org/10.1023/a:1020764227390openalex-snapshot
Capitalization versus Expensing: Evidence on the Uncertainty of Future Earnings from Capital Expenditures versus R&D Outlays
inferredcites →https://doi.org/10.1038/s41386-020-00911-5openalex-snapshot
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders
inferredcites →https://doi.org/10.1056/nejmoa1402582openalex-snapshot
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
inferredcites →https://doi.org/10.1086/430865openalex-snapshot
Biotech‐Pharmaceutical Alliances as a Signal of Asset and Firm Quality
inferredcites →https://doi.org/10.1093/biostatistics/kxx069openalex-snapshot
Estimation of clinical trial success rates and related parameters
inferredcites →https://doi.org/10.1111/j.1540-6261.2004.00696.xopenalex-snapshot
Characteristics, Contracts, and Actions: Evidence from Venture Capitalist Analyses
inferredcites →https://doi.org/10.1111/jofi.12867openalex-snapshot
What Is a Patent Worth? Evidence from the U.S. Patent “Lottery”
inferredcites →https://doi.org/10.1146/annurev-financial-031721-081537openalex-snapshot
Financing Biomedical Innovation
inferredcites →https://doi.org/10.1176/appi.ajp.2017.16121358openalex-snapshot
Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors
inferredcites →https://doi.org/10.1257/aer.20171742openalex-snapshot
Knowledge Spillovers and Corporate Investment in Scientific Research
inferredcites →https://doi.org/10.1257/aer.91.2.426openalex-snapshot
Venture Capitalists as Principals: Contracting, Screening, and Monitoring
inferredcites →https://doi.org/10.1287/mnsc.2015.2350openalex-snapshot
Financing Risk and Innovation
inferredcites →https://doi.org/10.1515/9781400830176openalex-snapshot
Investment under Uncertainty
inferredcites →https://doi.org/10.2307/1882010openalex-snapshot
Job Market Signaling
inferredcites →https://doi.org/10.2307/2393553openalex-snapshot
Absorptive Capacity: A New Perspective on Learning and Innovation
inferredcites →https://doi.org/10.2307/258557openalex-snapshot
Building Theories from Case Study Research
inferredcites →https://doi.org/10.3949/ccjm.85a.17018openalex-snapshot
Idiopathic pulmonary fibrosis: What primary care physicians need to know
inferredcites →https://doi.org/10.5465/amj.2007.24160888openalex-snapshot
Theory Building From Cases: Opportunities And Challenges
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.